🚀 Ariel Fund's Q3 2024 report is out! Thanks to a resilient economy and a soft landing, the fund surged +12.08%, outpacing the Russell 2500 Value (+9.63%) and Russell 2500 (+8.75%) indices.
🔍 Highlight: Bio-Rad Laboratories (NYSE:BIO) – a leader in life science and clinical diagnostics. Despite a flat year, the stock closed at $341.06 with a market cap of $9.474B. Ariel sees strong potential due to its diverse revenue streams and dominant market share.
💬 What are your thoughts on Bio-Rad's future? Drop your comments below! ⬇️
#Finance #Investing #Economy #Stocks #Crypto #Forex
🔍 Highlight: Bio-Rad Laboratories (NYSE:BIO) – a leader in life science and clinical diagnostics. Despite a flat year, the stock closed at $341.06 with a market cap of $9.474B. Ariel sees strong potential due to its diverse revenue streams and dominant market share.
💬 What are your thoughts on Bio-Rad's future? Drop your comments below! ⬇️
#Finance #Investing #Economy #Stocks #Crypto #Forex